It’s Not Just the P&T Committee. Payers Are Putting Value Assessment Committees, Filters on Drug Coverage Decisions | AMCP 2023

March 22, 2023

Managed Healthcare Executive

Related news

In the news

May 22, 2023

Payors Prepare for a Banner Crop of Biosimilars

Specialty Pharmacy Continuum

In the news

April 13, 2023

Prime, Magellan Studies Reveal Ways to Squeeze More Value From Specialty Drugs

AIS Health – Radar on Specialty Pharmacy